用户名： 密码： 验证码：
A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents
详细信息    查看全文
  • 作者：Michal Caspi ; Anastasia Firsow ; Raja Rajkumar ; Nir Skalka…
  • 关键词：Nonsense mutations ; Premature termination codons (PTCs) ; Genetic diseases ; Ribosomal read ; through ; Aminoglycoside and macrolide antibiotics
  • 刊名：Journal of Molecular Medicine
  • 出版年：2016
  • 出版时间：April 2016
  • 年：2016
  • 卷：94
  • 期：4
  • 页码：469-482
  • 全文大小：1,091 KB
  • 参考文献：1.Floquet C, Deforges J, Rousset JP, Bidou L (2011) Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucleic Acids Res 39:3350–3362CrossRef PubMed PubMedCentral
    2.Bidou L, Allamand V, Rousset JP, Namy O (2012) Sense from nonsense: therapies for premature stop codon diseases. Trends Mol Med 18:679–688CrossRef PubMed
    3.Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A (2007) Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther 81:99–103CrossRef PubMed
    4.Frischmeyer PA, Dietz HC (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8:1893–1900CrossRef PubMed
    5.Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411–414CrossRef PubMed
    6.Burke JF, Mogg AE (1985) Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 13:6265–6272CrossRef PubMed PubMedCentral
    7.Nguyen LS, Wilkinson MF, Gecz J (2014) Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci Biobehav Rev 46P2:175–186CrossRef
    8.Keeling KM, Wang D, Conard SE, Bedwell DM (2012) Suppression of premature termination codons as a therapeutic approach. Crit Rev Biochem Mol Biol 47:444–463CrossRef PubMed PubMedCentral
    9.Martin R, Mogg AE, Heywood LA, Nitschke L, Burke JF (1989) Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells. Mol Gen Genet MGG 217:411–418CrossRef PubMed
    10.Bidou L, Hatin I, Perez N, Allamand V, Panthier JJ, Rousset JP (2004) Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. Gene Ther 11:619–627CrossRef PubMed
    11.Manuvakhova M, Keeling K, Bedwell DM (2000) Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 6:1044–1055CrossRef PubMed PubMedCentral
    12.Floquet C, Hatin I, Rousset JP, Bidou L (2012) Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin. PLoS Genet 8:e1002608CrossRef PubMed PubMedCentral
    13.Zilberberg A, Lahav L, Rosin-Arbesfeld R (2010) Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons. Gut 59:496–507CrossRef PubMed
    14.Nudelman I, Glikin D, Smolkin B, Hainrichson M, Belakhov V, Baasov T (2010) Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. Bioorg Med Chem 18:3735–3746CrossRef PubMed
    15.Maire I (2001) Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases? J Inherit Metab Dis 24(Suppl 2):57–61, discussion 45–56 CrossRef PubMed
    16.Kerem E (2004) Pharmacologic therapy for stop mutations: how much CFTR activity is enough? Curr Opin Pulm Med 10:547–552CrossRef PubMed
    17.Lee HL, Dougherty JP (2012) Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther 136:227–266CrossRef PubMed
    18.Nagel-Wolfrum K, Moller F, Penner I, Wolfrum U (2014) Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations. Vis Neurosci 31:309–316CrossRef PubMed
    19.Auld DS, Thorne N, Maguire WF, Inglese J (2009) Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci U S A 106:3585–3590CrossRef PubMed PubMedCentral
    20.Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631–639CrossRef PubMed
    21.da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRef
    22.Salas-Marco J, Bedwell DM (2005) Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol 348:801–815CrossRef PubMed
    23.Keeling KM, Lanier J, Du M, Salas-Marco J, Gao L, Kaenjak-Angeletti A, Bedwell DM (2004) Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae. RNA 10:691–703CrossRef PubMed PubMedCentral
    24.Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF, Atkins JF (1998) A dual-luciferase reporter system for studying recoding signals. RNA 4:479–486CrossRef PubMed PubMedCentral
    25.Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF (2000) Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164–169CrossRef PubMed
    26.Kallmeyer AK, Keeling KM, Bedwell DM (2006) Eukaryotic release factor 1 phosphorylation by CK2 protein kinase is dynamic but has little effect on the efficiency of translation termination in Saccharomyces cerevisiae. Eukaryot Cell 5:1378–1387CrossRef PubMed PubMedCentral
    27.Salas-Marco J, Fan-Minogue H, Kallmeyer AK, Klobutcher LA, Farabaugh PJ, Bedwell DM (2006) Distinct paths to stop codon reassignment by the variant-code organisms Tetrahymena and Euplotes. Mol Cell Biol 26:438–447CrossRef PubMed PubMedCentral
    28.Fan-Minogue H, Bedwell DM (2008) Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA 14:148–157CrossRef PubMed PubMedCentral
    29.Zomer-van Ommen DD, Vijftigschild LA, Kruisselbrink E, Vonk AM, Dekkers JF, Janssens HM, de Winter-de Groot KM, van der Ent CK, Beekman JM (2015) Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids. J Cyst Fibros Off J Eur Cyst Fibros Soc
    30.McElroy SP, Nomura T, Torrie LS, Warbrick E, Gartner U, Wood G, McLean WH (2013) A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays. PLoS Biol 11:e1001593CrossRef PubMed PubMedCentral
    31.Dranchak PK, Di Pietro E, Snowden A, Oesch N, Braverman NE, Steinberg SJ, Hacia JG (2011) Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. J Cell Biochem 112:1250–1258CrossRef PubMed PubMedCentral
    32.Harmer SC, Mohal JS, Kemp D, Tinker A (2012) Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel. Biochem J 443:635–642CrossRef PubMed
    33.Brumm H, Muhlhaus J, Bolze F, Scherag S, Hinney A, Hebebrand J, Wiegand S, Klingenspor M, Gruters A, Krude H et al (2012) Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through. Obesity (Silver Spring) 20:1074–1081CrossRef
    34.Koopmann TT, Verkerk AO, Bezzina CR, de Bakker JM, Wilde AA (2012) The chemical compound PTC124 does not affect cellular electrophysiology of cardiac ventricular myocytes. Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother 26:41–45CrossRef
    35.Gomez-Grau M, Garrido E, Cozar M, Rodriguez-Sureda V, Dominguez C, Arenas C, Gatti RA, Cormand B, Grinberg D, Vilageliu L (2015) Evaluation of aminoglycoside and non-aminoglycoside compounds for stop-codon readthrough therapy in four lysosomal storage diseases. PLoS One 10:e0135873CrossRef PubMed PubMedCentral
    36.Tan L, Narayan SB, Chen J, Meyers GD, Bennett MJ (2011) PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation. J Inherit Metab Dis 34:443–447CrossRef PubMed
    37.Goldmann T, Overlack N, Wolfrum U, Nagel-Wolfrum K (2011) PTC124-mediated translational readthrough of a nonsense mutation causing usher syndrome type 1C. Hum Gene Ther 22:537–547CrossRef PubMed
    38.Sarkar C, Zhang Z, Mukherjee AB (2011) Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients. Mol Genet Metab 104:338–345CrossRef PubMed PubMedCentral
    39.Matalonga L, Arias A, Tort F, Ferrer-Cortes X, Garcia-Villoria J, Coll MJ, Gort L, Ribes A (2015) Effect of readthrough treatment in fibroblasts of patients affected by lysosomal diseases caused by premature termination codons. Neurother J Am Soc Exp Neurother
    40.Pibiri I, Lentini L, Melfi R, Gallucci G, Pace A, Spinello A, Barone G, Di Leonardo A (2015) Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives. Eur J Med Chem 101:236–244CrossRef PubMed
    41.Perlman S, Becker-Catania S, Gatti RA (2003) Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 10:173–182CrossRef PubMed
    42.Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499–506CrossRef PubMed
    43.Dragich J, Houwink-Manville I, Schanen C (2000) Rett syndrome: a surprising result of mutation in MECP2. Hum Mol Genet 9:2365–2375CrossRef PubMed
    44.Vecsler M, Ben Zeev B, Nudelman I, Anikster Y, Simon AJ, Amariglio N, Rechavi G, Baasov T, Gak E (2011) Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations. PLoS One 6:e20733CrossRef PubMed PubMedCentral
    45.Farrar MA, Kiernan MC (2014) The genetics of spinal muscular atrophy: progress and challenges. Neurother J Am Soc Exp Neurother
    46.Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170CrossRef PubMed
    47.Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P (1993) Association of the APC gene product with beta-catenin. Science 262:1731–1734CrossRef PubMed
    48.Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF, Tomlinson IP (2000) APC mutations in sporadic colorectal tumors: a mutational “hotspot” and interdependence of the “two hits”. Proc Natl Acad Sci U S A 97:3352–3357CrossRef PubMed PubMedCentral
    49.Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322–324CrossRef PubMed
    50.Tate WP, Poole ES, Horsfield JA, Mannering SA, Brown CM, Moffat JG, Dalphin ME, McCaughan KK, Major LL, Wilson DN (1995) Translational termination efficiency in both bacteria and mammals is regulated by the base following the stop codon. Biochem Cell Biol 73:1095–1103CrossRef PubMed
    51.Bonetti B, Fu L, Moon J, Bedwell DM (1995) The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol 251:334–345CrossRef PubMed
    52.Brown CM, Stockwell PA, Trotman CN, Tate WP (1990) Sequence analysis suggests that tetra-nucleotides signal the termination of protein synthesis in eukaryotes. Nucleic Acids Res 18:6339–6345CrossRef PubMed PubMedCentral
    53.Cavener DR, Ray SC (1991) Eukaryotic start and stop translation sites. Nucleic Acids Res 19:3185–3192CrossRef PubMed PubMedCentral
    54.Liu Q (2005) Comparative analysis of base biases around the stop codons in six eukaryotes. Biosystems 81:281–289CrossRef PubMed
    55.Phillips-Jones MK, Hill LS, Atkinson J, Martin R (1995) Context effects on misreading and suppression at UAG codons in human cells. Mol Cell Biol 15:6593–6600CrossRef PubMed PubMedCentral
    56.Martin R, Phillips-Jones MK, Watson FJ, Hill LS (1993) Codon context effects on nonsense suppression in human cells. Biochem Soc Trans 21:846–851CrossRef PubMed
    57.Harrell L, Melcher U, Atkins JF (2002) Predominance of six different hexanucleotide recoding signals 3′ of read-through stop codons. Nucleic Acids Res 30:2011–2017CrossRef PubMed PubMedCentral
    58.Pacho F, Zambruno G, Calabresi V, Kiritsi D, Schneider H (2011) Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon. J Med Genet 48:640–644CrossRef PubMed
    59.Sun J, Chen M, Xu J, Luo J (2005) Relationships among stop codon usage bias, its context, isochores, and gene expression level in various eukaryotes. J Mol Evol 61:437–444CrossRef PubMed
    60.Hu T, Li C (2010) Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 9:236CrossRef PubMed PubMedCentral
  • 作者单位：Michal Caspi (1)
    Anastasia Firsow (1)
    Raja Rajkumar (1)
    Nir Skalka (1)
    Itay Moshkovitz (1)
    Ariel Munitz (1)
    Metsada Pasmanik-Chor (2)
    Hagar Greif (3)
    Dalia Megido (3)
    Revital Kariv (4)
    Daniel W. Rosenberg (5)
    Rina Rosin-Arbesfeld (1)

    1. Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Ramat-Aviv, 69978, Tel Aviv, Israel
    2. Bioinformatics Unit, G.S.W. Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel
    3. Bioblast Pharma, Tel Aviv, Israel
    4. Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel
    5. Center for Molecular Medicine, University of Connecticut School of Medicine, Farmington, CT, USA
  • 刊物类别：Biomedical and Life Sciences
  • 刊物主题：Biomedicine
    Molecular Medicine
    Internal Medicine
  • 出版者：Springer Berlin / Heidelberg
  • ISSN：1432-1440
文摘

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址：北京市海淀区学院路29号 邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700